Your browser doesn't support javascript.
loading
Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study.
Lombardi, Francesca; Belmonti, Simone; Fabbiani, Massimiliano; Borghetti, Alberto; Cauda, Roberto; De Luca, Andrea; Di Giambenedetto, Simona.
Afiliação
  • Lombardi F; Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy.
  • Belmonti S; Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy.
  • Fabbiani M; Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy.
  • Borghetti A; Division of Infectious Diseases, Department of Internal Medicine, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
  • Cauda R; Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy al.bor86@gmail.com.
  • De Luca A; Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy.
  • Di Giambenedetto S; Department of Medical Biotechnologies, University of Siena, Viale Bracci 16, 53100 Siena, Italy.
J Antimicrob Chemother ; 71(12): 3621-3622, 2016 12.
Article em En | MEDLINE | ID: mdl-27494930
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Viral / Infecções por HIV / HIV / Ritonavir / Lamivudina / Sulfato de Atazanavir Limite: Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Viral / Infecções por HIV / HIV / Ritonavir / Lamivudina / Sulfato de Atazanavir Limite: Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália